Package 50242-150-01
Brand: ocrevus
Generic: ocrelizumabPackage Facts
Identity
Package NDC
50242-150-01
Digits Only
5024215001
Product NDC
50242-150
Description
1 VIAL, SINGLE-USE in 1 CARTON (50242-150-01) / 10 mL in 1 VIAL, SINGLE-USE
Marketing
Marketing Status
Brand
ocrevus
Generic
ocrelizumab
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "38590bd9-ff82-44dc-98aa-ed5936351017", "openfda": {"nui": ["N0000175078", "N0000175657", "M0001357", "M0556300"], "unii": ["A10SJL62JY"], "rxcui": ["1876380", "1876385"], "spl_set_id": ["9da42362-3bb5-4b83-b4bb-b59fd4e55f0d"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]", "Antibodies, Monoclonal, Humanized [CS]"], "pharm_class_epc": ["CD20-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["CD20-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-150-01) / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-150-01", "marketing_start_date": "20170328"}], "brand_name": "OCREVUS", "product_id": "50242-150_38590bd9-ff82-44dc-98aa-ed5936351017", "dosage_form": "INJECTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Antibodies", "Monoclonal", "Humanized [CS]", "CD20-directed Antibody Interactions [MoA]", "CD20-directed Cytolytic Antibody [EPC]"], "product_ndc": "50242-150", "generic_name": "ocrelizumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OCREVUS", "active_ingredients": [{"name": "OCRELIZUMAB", "strength": "300 mg/10mL"}], "application_number": "BLA761053", "marketing_category": "BLA", "marketing_start_date": "20170328", "listing_expiration_date": "20261231"}